Physician profile
Gary Dykstra
NPI 1033172192
$962.39
in general payments reported to CMS, 2019-2025
16 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $112 · 2021: $104 · 2022: $41.96 · 2023: $57.32 · 2024: $115 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $236.69 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $138.09 | 2019-2020 | |
| Abbott Laboratories | $125.14 | 2025 | Cardiomems, Amplatzer Talisman |
| Pfizer INC. | $66.09 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $62.79 | 2025 | |
| Amgen INC. | $57.41 | 2024-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $48.76 | 2022-2025 | Farxiga |
| Boston Scientific Corporation | $34.97 | 2020-2021 | |
| Abiomed | $33.34 | 2025 | |
| Janssen Pharmaceuticals, INC | $31.28 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $28.71 | 2025 | Wegovy |
| Innovation Technologies INC | $26.94 | 2025 | Irrisept |
| Philips North America LLC | $24.55 | 2024 | (Br5) Peripheral Ivus |
| Lexicon Pharmaceuticals, INC. | $19.18 | 2024 | |
| Scpharmaceuticals INC. | $17.44 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Dykstra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.